Search details
1.
The splicing factor U2AF1 contributes to cancer progression through a noncanonical role in translation regulation.
Genes Dev
; 33(9-10): 482-497, 2019 05 01.
Article
in English
| MEDLINE | ID: mdl-30842218
2.
How I treat AML incorporating the updated classifications and guidelines.
Blood
; 141(23): 2813-2823, 2023 06 08.
Article
in English
| MEDLINE | ID: mdl-36758209
3.
Quantification of measurable residual disease using duplex sequencing in adults with acute myeloid leukemia.
Haematologica
; 109(2): 401-410, 2024 Feb 01.
Article
in English
| MEDLINE | ID: mdl-37534515
4.
Test Then Erase? Current Status and Future Opportunities for Measurable Residual Disease Testing in Acute Myeloid Leukemia.
Acta Haematol
; 147(2): 133-146, 2024.
Article
in English
| MEDLINE | ID: mdl-38035547
5.
Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease.
N Engl J Med
; 383(27): 2628-2638, 2020 12 31.
Article
in English
| MEDLINE | ID: mdl-33108101
6.
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party.
Blood
; 138(26): 2753-2767, 2021 12 30.
Article
in English
| MEDLINE | ID: mdl-34724563
7.
Measurable residual disease monitoring in patients with acute myeloid leukemia treated with lower-intensity therapy: Roadmap from an ELN-DAVID expert panel.
Am J Hematol
; 98(12): 1847-1855, 2023 12.
Article
in English
| MEDLINE | ID: mdl-37671649
8.
DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell Transplant.
JAMA
; 329(9): 745-755, 2023 03 07.
Article
in English
| MEDLINE | ID: mdl-36881031
9.
The present and future of measurable residual disease testing in acute myeloid leukemia.
Haematologica
; 107(12): 2810-2822, 2022 12 01.
Article
in English
| MEDLINE | ID: mdl-36453518
10.
Utility of plasma cell-free DNA for de novo detection and quantification of clonal hematopoiesis.
Haematologica
; 107(8): 1815-1826, 2022 08 01.
Article
in English
| MEDLINE | ID: mdl-34587721
11.
Heterogeneity in refractory acute myeloid leukemia.
Proc Natl Acad Sci U S A
; 116(21): 10494-10503, 2019 05 21.
Article
in English
| MEDLINE | ID: mdl-31064876
12.
Next-generation sequencing for measurable residual disease detection in acute myeloid leukaemia.
Br J Haematol
; 188(1): 77-85, 2020 01.
Article
in English
| MEDLINE | ID: mdl-31804716
13.
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party.
Blood
; 131(12): 1275-1291, 2018 03 22.
Article
in English
| MEDLINE | ID: mdl-29330221
14.
Microtransplantation in older patients with AML: A pilot study of safety, efficacy and immunologic effects.
Am J Hematol
; 95(6): 662-671, 2020 06.
Article
in English
| MEDLINE | ID: mdl-32162718
15.
The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia.
Cancer
; 125(9): 1470-1481, 2019 05 01.
Article
in English
| MEDLINE | ID: mdl-30500073
16.
Pathogenic TERT promoter variants in telomere diseases.
Genet Med
; 21(7): 1594-1602, 2019 07.
Article
in English
| MEDLINE | ID: mdl-30523342
17.
Increased incidence of hematologic malignancies in SCD after HCT in adults with graft failure and mixed chimerism.
Blood
; 140(23): 2514-2518, 2022 12 08.
Article
in English
| MEDLINE | ID: mdl-36044658
18.
Targeted RNA-sequencing for the quantification of measurable residual disease in acute myeloid leukemia.
Haematologica
; 104(2): 297-304, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30171026
19.
DNA Sequencing in Adults With Acute Myeloid Leukemia to Detect Residual Disease Prior to Hematopoietic Cell Transplant-Reply.
JAMA
; 330(2): 190-191, 2023 07 11.
Article
in English
| MEDLINE | ID: mdl-37432432
20.
Impaired B cell immunity in acute myeloid leukemia patients after chemotherapy.
J Transl Med
; 15(1): 155, 2017 07 10.
Article
in English
| MEDLINE | ID: mdl-28693586